HenterJIHorneAAricóM, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-131.
3.
EhlSAstigarragaIvon Bahr GreenwoodT, et al. Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH Steering Committee of the Histiocyte Society. J Allergy Clin Immunol Pract. 2018;6(5):1508-1517.
4.
HardmanSJTukurGWaruiruC.Enterovirus-associated HLH: addition of anakinra to IVIG and corticosteroids. J Clin Immunol. 2019;39(4):373-375.
5.
HorneARammeKGRuddE, et al. Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis. Br J Haematol. 2008;143:75-83.
6.
Molleran LeeSVillanuevaJSumegiJ, et al. Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet. 2004;41:137-144.
